SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

BUYINS.NET: Market Maker Surveillance Report. AMRI, AVP, OSBC, ZIOP, RSOL, ZNNMF, Winning Stocks With Lowest Price Friction For Tuesday, February 12th 2013
[February 13, 2013]

BUYINS.NET: Market Maker Surveillance Report. AMRI, AVP, OSBC, ZIOP, RSOL, ZNNMF, Winning Stocks With Lowest Price Friction For Tuesday, February 12th 2013

(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 3957 companies with "abnormal" market making, 3100 companies with positive Friction Factors and 2248 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Albany Molecular Research Inc (NASDAQ:AMRI), Avon Products Inc (NYSE:AVP), Old Second Bancorp Inc (NASDAQ:OSBC), ZIOPHARM Oncology Inc (NASDAQ:ZIOP), Real Goods Solar Inc (NASDAQ:RSOL), ZENN MOTOR CO INC (OTC:ZNNMF). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below: Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction AMRI $0.890 15.72% 556,893 48.55% 551,005 48.04% 5,888 66 AVP $3.610 20.89% 10,934,185 34.59% 10,592,037 33.50% 342,148 948 OSBC $0.630 25.10% 143,658 59.33% 98,465 40.67% 45,193 717 ZIOP $0.710 17.79% 3,786,558 51.95% 3,499,706 48.01% 286,852 4,040 RSOL $0.400 36.04% 224,387 52.94% 199,464 47.06% 24,923 623 ZNNMF $0.235 17.42% 59,032 47.61% 41,804 33.72% 17,228 732 Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows AMRI with a dollar gain Tuesday of $0.89000 and a Friction Factor of 66 shares. That means that it only took 66 more shares of buying than selling to move AMRI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.


Albany Molecular Research Inc (NASDAQ:AMRI) - Albany Molecular Research, Inc. provides various drug discovery, development, and manufacturing services in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services comprising process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services; and chemical synthesis and manufacturing services. In addition, the company offers contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals; and formulation services, such as aseptic fill and finish, aseptic lyophilization, neat active pharmaceutical ingredients or pharmaceutical blend in capsules, powder in bottle for solution and suspension, blending and sieving, milling, tableting, rheology, roller compaction, wet granulation, and fluid bed processing, as well as associated analytical testing services for dosage formulation products. Further, it provides various analytical chemistry services consisting of impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; laboratory practices bioanalytical services; and regulatory support/quality assurance services. It serves pharmaceutical and biotechnology companies. The company was founded in 1991 and is based in Albany, New York..

Avon Products Inc (NYSE:AVP) - Avon Products, Inc. manufactures and markets beauty and related products worldwide. It offers beauty products, such as color cosmetics, fragrances, skin care, and personal care products; fashion products comprising fashion jewelry, watches, apparel, footwear, accessories, and children s products; and home products consisting of gift and decorative products, house wares, entertainment and leisure products, and nutritional products. The company markets its products through direct selling and independent representatives. Avon Products, Inc. was founded in 1886 and is headquartered in New York, New York..

Old Second Bancorp Inc (NASDAQ:OSBC) - Old Second Bancorp, Inc. operates as the bank holding company for Old Second National Bank that provides commercial and retail banking services to corporations, partnerships, individuals, and government agencies in India. The company offers demand, NOW, money market, savings, time deposit, individual retirement, and Keogh deposit accounts. It also provides commercial loans, including lines of credit for working capital and operational purposes, and term loans for the acquisition of equipment; commercial real estate loans; construction loans; residential real estate loans consisting of residential first mortgages, second mortgages, and home equity line of credit mortgages; and consumer loans, including motor vehicle, home improvement, and signature loans, as well as small personal credit lines. In addition, the company offers safe deposit operations; trust and wealth management services; and other banking services, including traveler s checks, money orders, cashier s checks, foreign currency, direct deposits, discount brokerage, debit cards, and credit cards. Further, it provides electronic banking services, such as Internet banking; and corporate cash management products, including remote deposit capture, investment sweep accounts, zero balance accounts, automated tax payments, ATM access, telephone banking, lockboxes, automated clearing house transactions, account reconciliation, controlled disbursement, detail and general information reporting, wire transfers, vault services, and checking accounts. Additionally, the company offers trust, investment, agency, and custodial services for individual, corporate, and not-for-profit clients. As of December 31, 2011, it operated 27 branches in Kane, Kendall, LaSalle, Will, DeKalb, DuPage, and southwestern Cook counties. The company was founded in 1982 and is headquartered in Aurora, Illinois..

ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of new cancer therapies. Its lead candidate, Palifosfamide (ZIO-201), a potent bi-functional DNA alkylating agent, is under Phase III trial for the treatment of first-line metastatic soft tissue sarcoma, as well as in a pivotal Phase III trial for first-line metastatic small cell lung cancer. The company s portfolio of clinical-stage product candidates also include IL-12 DNA, which is being tested in a Phase 2 study using synthetic biology to enable controlled, local delivery of therapeutic interleukin-12; Indibulin (ZIO-301), a novel, tubulin binding agent under Phase I/II trial in metastatic breast cancer; and Darinaparsin (ZIO-101), a novel mitochondrial- and hedgehog-targeted agent. In addition, its portfolio comprises various research-stage candidates. The company s DNA therapeutics are being developed in partnership with Intrexon Corporation through a synthetic biology platform that allows for targeted, controlled production of therapies in humans with a biologic on/off switch. ZIOPHARM Oncology, Inc. was founded in 2003 and is headquartered in New York, New York with operations center located in Boston, Massachusetts..

Real Goods Solar Inc (NASDAQ:RSOL) - Real Goods Solar, Inc. operates as a residential and commercial solar energy integrator primarily in California and Colorado. The company provides engineering, procurement, and construction services. It offers various turnkey solar energy services, including design, procurement, permitting, build-out, grid connection, financing referrals, and warranty and customer satisfaction services. The company installs residential and small commercial systems that range between 3 kilowatts and 1 megawatt output. It also engages in the retail sale of renewable energy products. The company was founded in 1978 and is based in Louisville, Colorado..

ZENN MOTOR CO INC (OTC:ZNNMF) - ZENN Motor Company Inc., a development stage company, focuses on providing power storage solutions and related technologies to the automotive industry. The company has technology agreement with EEStor, Inc. that provides certain exclusive and non-exclusive rights to purchase and deploy Electrical Energy Storage Unit (EESU), a high-energy-density ceramic ultra capacitor. It intends to supply its products to new vehicles, specialty vehicles, and used vehicles for original equipment manufacturers, tier 1 companies, and conversion upfitters. The company was formerly known as Feel Good Cars Corporation and changed its name to ZENN Motor Company Inc. in June 2007. ZENN Motor Company Inc. is headquartered in Toronto, Canada..

About BUYINS.NET BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO INVESTMENTS & TRADING SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER: BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net CONTACT: Buyins.net Thomas Ronk tom@buyins.net www.buyins.net ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com)).

(c) 2013 M2 COMMUNICATIONS

[ Back To TMCnet.com's Homepage ]





LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved.